Single-Use Bioprocessing Market to Hit USD 116.3 Bn by 2032 as Biopharmaceutical Adoption Accelerate
09 Feb, 2026
SAN FRANCISCO – Feb. 9, 2026 – PRLog — Single-Use Bioprocessing Market is on a robust global growth trajectory, with market analysts forecasting a rise from USD 26.1 billion in 2022 to an estimated USD 116.3 billion by 2032, expanding at an impressive compound annual growth rate (CAGR) of 16.2% between 2023 and 2032. This substantial increase is being driven by rapidly expanding biopharmaceutical production, growing adoption of flexible manufacturing platforms, and advancements in disposable bioprocess technologies that enhance efficiency and reduce contamination risks in drug manufacturing.
Single-Use Bioprocessing Market Statistics
From Single-Use Bioprocessing Market Report, key figures underscore rapid growth and scaling potential of the market:
- Single-Use Bioprocessing Market Size (2022): USD 26.1 Billion
- Projected Market Value (2032): USD 116.3 Billion
- Forecasted CAGR (2023–2032): 16.2% CAGR
- North America Share (2022): ~34% of global revenue
- Dominant Product Segment: Media bags and containers with >44% share in 2022
- Fastest-Growing Region: Asia-Pacific projected for rapid expansion
Download PDF Sample Report: https://tinyurl.com/nhea9x9t
Read full news at Globenewswire: https://www.globenewswire.com/news-release/2023/08/02/2717069/0/en/Single-Use-Bioprocessing-Market-Size-Predictions-suggest-a-rise-of-16-2-CAGR-to-reach-value-of-USD-116-3-Billion-by-2032.html
Single-Use Bioprocessing Market Trends and Analysis
Single-Use Bioprocessing Market Trends reveal several transformative industry developments:
- Rapid Biologics Growth: Growing development and commercialization of monoclonal antibodies, vaccines, and gene therapies are major drivers of single-use bioprocessing adoption.
- Operational Efficiency: Single-use systems help biopharmaceutical manufacturers reduce downtime and streamline operations with faster changeovers and simplified cleaning procedures.
- Enhanced Technology Integration: Innovations such as advanced sensors, automated process controls, and smart monitoring are improving system performance and data-driven decision-making in real time.
- Outsourcing Trends: Contract Manufacturing Organizations (CMOs) and Contract Development and Manufacturing Organizations (CDMOs) are increasingly adopting single-use technologies to support flexible production and manage diverse biotherapeutic portfolios.
Key Driving Factors
Several core factors are propelling Single-Use Bioprocessing Market Growth:
- Increasing global demand for biologics and other complex therapies requiring flexible manufacturing infrastructure.
- Continued R&D investment in biopharmaceutical processes and technologies.
- Shift toward modular and disposable manufacturing platforms that improve agility and reduce capital expenditure.
- Enhanced regulatory support and standardization encouraging broader adoption of single-use systems.
Leading Companies in the Single-Use Bioprocessing Market
Major players contributing significantly to Single-Use Bioprocessing Market Share include:
- Thermo Fisher Scientific
- Danaher Corporation
- Sartorius AG
- Merck KGaA (MilliporeSigma)
- Eppendorf AG
- Repligen Corporation
- 3M Company
- Entegris, Inc.
- Saint-Gobain Performance Plastics
- Parker Hannifin Corporation
- Avantor, Inc.
- Meissner Filtration Products, Inc.
